missing translation for 'onlineSavingsMsg'
Learn More
Learn More
ACROBiosystems Human BMPR-IA / ALK-3 Protein, Fc Tag
Marca: ACROBiosystems AL3-H5259-1MG
Este artículo no se puede devolver.
Vea la política de devoluciones
Descripción
The bone morphogenetic protein receptor, type IA is also known as BMPR1A or ALK3 is a protein which in humans is encoded by the BMPR1A gene. BMPR1A has also been designated as CD292 (cluster of differentiation 290). The bone morphogenetic protein (BMP) receptors are a family of transmembrane serine/threonine kinases that include the type I receptors BMPR1A (this protein) and BMPR1B and the type II receptor BMPR2. These receptors are also closely related to the activin receptors, ACVR1 and ACVR2[1]. Alk3-mediated BMP signaling in AV endocardial/mesenchymal cells plays a central role during cushion morphogenesis.
This protein carries a human IgG1 Fc tag at the C-terminus. The protein has a calculated MW of 40.3 kDa. The protein migrates as 56 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation.Especificaciones
| CAA80257 | |
| 1 mg | |
| Gln 24 - Arg 152 | |
| BMPR-1 A,ALK-3,10q23del,ACVRLK3,CD292,SKR5 | |
| Unconjugated | |
| Fc Tag | |
| Less than 1.0 EU / μg by the LAL method. | |
| Powder | |
| >98% as determined by SDS-PAGE |
| 40.3 kDa | |
| Human BMPR-IA, Fc Tag (AL3-H5259) is expressed from human 293 cells (HEK293). It contains AA Gln 24 - Arg 152 (Accession # P36894-1). | |
| -20°C | |
| BMPR-IA | |
| Human | |
| 50 mM Tris, 100 mM Glycine, pH7.5 | |
| HEK293 | |
| Bio-Markers and CD Antigens |
Corrección del contenido de un producto
El Programa Encompass de Fisher Scientific ofrece artículos que no forman parte de nuestra cartera de distribución. Estos productos no suelen tener imágenes ni descripciones detalladas. Sin embargo, nos comprometemos a mejorar su experiencia de compra. Utilice el siguiente formulario para hacernos llegar sus comentarios sobre el contenido de este producto.
Título del producto
ACROBiosystems Human BMPR-IA / ALK-3 Protein, Fc Tag
¿Detecta una oportunidad de mejora?Comparta una corrección de contenido